“Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s273. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/2387.